TY - JOUR
AU - A. Wright
AU - M. Carr
AU - E. Kontopantelis
AU - L. Leelarathna
AU - H. Thabit
AU - R. Emsley
AU - I. Buchan
AU - M. Mamas
AU - T. van Staa
AU - N. Sattar
AU - D. Ashcroft
AU - M. Rutter
AD - Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, University of Manchester, Manchester, U.K.
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, U.K.
National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester, U.K.
Division of Population Health, Health Services and Primary Care, School of Health Sciences, University of Manchester, Manchester, U.K.
Diabetes, Endocrinology and Metabolism Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, U.K.
Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, U.K.
Institute of Population Health, University of Liverpool, Liverpool, U.K.
Keele Cardiovascular Group, Centre for Prognosis Research, Keele University, Keele, U.K.
Division of Informatics, Imaging and Data Sciences, School of Health Sciences, University of Manchester, Manchester, U.K.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.
AN - 35100355
BT - Diabetes Care
DO - 10.2337/dc21-1113
DP - NLM
ET - 2022/02/01
LA - eng
N1 - 1935-5548
Wright, Alison K
Orcid: 0000-0002-8418-8332
Carr, Matthew J
Orcid: 0000-0001-7336-1606
Kontopantelis, Evangelos
Orcid: 0000-0001-6450-5815
Leelarathna, Lalantha
Thabit, Hood
Emsley, Richard
Buchan, Iain
Mamas, Mamas A
van Staa, Tjeerd P
Sattar, Naveed
Orcid: 0000-0002-1604-2593
Ashcroft, Darren M
Rutter, Martin K
Journal Article
United States
Diabetes Care. 2022 Jan 31:dc211113. doi: 10.2337/dc21-1113.
PY - 2022
SN - 0149-5992
T2 - Diabetes Care
TI - Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
ER -